Jim Cramer on CVS: “I Think It’s a Fascinating Time to Own the Stock”

CVS Health Corporation (NYSE:CVS) is one of the stocks in focus on Jim Cramer’s game plan. Cramer highlighted the stock’s catalysts and the company CEO’s performance, as he commented:

On Tuesday, we’re back in heavy earnings rotation. We’ve got DuPont, Coca-Cola, CVS Health, AstraZeneca, Datadog, and S&P Global report… CVS is now less of a drug store than a managed care company, which is, theirs is called Aetna. The stock got hammered not that long ago, and we learned that the government will barely raise reimbursement rates for Medicare Advantage plans this year. It was a disaster for the health insurers.

The only one I want to own is CVS, which reports Tuesday morning. CEO David Joyner’s done a terrific job, and I think it’s a fascinating time to own the stock… You know what, they’re the last real national drugstore chain now that Walgreens has been taken private, and the one-time giant Rite Aid has closed all of its stores. Now, how do you like that?

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail pharmacy services.

While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.